share_log

阿里健康：授出受限制股份單位

ALI HEALTH: GRANT OF RESTRICTED SHARE UNITS

香港交易所 ·  Mar 15 08:26
Summary by Moomoo AI
阿里健康信息技術有限公司於2024年3月15日向12名僱員授出合共1,929,300個受限制股份單位，該授出行為是根據公司股份獎勵計劃的條款進行的。這些受限制股份單位將在二至四年內歸屬於承授人，且不受表現目標限制。授出的目的旨在獎勵員工對集團成功和發展的貢獻，並激勵他們為公司的未來發展和擴張努力。授出的受限制股份單位在授出時的購買價格為零，而股份在授出日期的收市價為每股3.360港元。根據股份獎勵計劃，未來仍可授出超過1.34億股與認股權及受限制股份單位相關的股份。董事會確認，所有授出的受限制股份單位均符合上市規則的要求。
阿里健康信息技術有限公司於2024年3月15日向12名僱員授出合共1,929,300個受限制股份單位，該授出行為是根據公司股份獎勵計劃的條款進行的。這些受限制股份單位將在二至四年內歸屬於承授人，且不受表現目標限制。授出的目的旨在獎勵員工對集團成功和發展的貢獻，並激勵他們為公司的未來發展和擴張努力。授出的受限制股份單位在授出時的購買價格為零，而股份在授出日期的收市價為每股3.360港元。根據股份獎勵計劃，未來仍可授出超過1.34億股與認股權及受限制股份單位相關的股份。董事會確認，所有授出的受限制股份單位均符合上市規則的要求。
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. GRANTED A TOTAL OF 1,929,300 RESTRICTED STOCK UNITS TO 12 EMPLOYEES ON MARCH 15, 2024, UNDER THE TERMS OF THE COMPANY'S SHARE REWARD PROGRAM. These restricted units will belong to the grantor within two to four years and are not subject to performance targets. The purpose of the award is to reward employees for their contribution to the success and development of the Group and to motivate their efforts for the future development and expansion of the company. The issued restricted share units had a purchase price of zero at the time of issue and the closing price of the shares at the date of issue was HK$3.360 per share. Under the Share Award Scheme, more than 1.34 million shares related to the preferred stock and restricted share units will still be granted in the future. The Board of Directors confirms that all restricted share units granted comply with the requirements of the Listing Rules.
ALI HEALTH INFORMATION TECHNOLOGY CO., LTD. GRANTED A TOTAL OF 1,929,300 RESTRICTED STOCK UNITS TO 12 EMPLOYEES ON MARCH 15, 2024, UNDER THE TERMS OF THE COMPANY'S SHARE REWARD PROGRAM. These restricted units will belong to the grantor within two to four years and are not subject to performance targets. The purpose of the award is to reward employees for their contribution to the success and development of the Group and to motivate their efforts for the future development and expansion of the company. The issued restricted share units had a purchase price of zero at the time of issue and the closing price of the shares at the date of issue was HK$3.360 per share. Under the Share Award Scheme, more than 1.34 million shares related to the preferred stock and restricted share units will still be granted in the future. The Board of Directors confirms that all restricted share units granted comply with the requirements of the Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more